We are live on
!
Find out more
CNFG
Creegan & Nassoura Financial Group Portfolio holdings
AUM
$154M
1-Year Est. Return
17.18%
This Fund
S&P 500
This Quarter
Est. Return
+8.65%
1 Year Est. Return
+17.18%
3 Year Est. Return
+52.61%
5 Year Est. Return
+77.6%
10 Year Est. Return
–
AUM
$159M
AUM Growth
+$13.1M
(+9%)
Cap. Flow
+$1.62M
Cap. Flow
% of AUM
1.02%
Top 10 Holdings %
Top 10 Hldgs %
35.21%
Holding
80
New
2
Increased
8
Reduced
34
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$1.27M |
| 2 |
Diageo
DEO
|
+$1.2M |
| 3 |
Eli Lilly
LLY
|
+$209K |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$207K |
| 5 |
Blackrock
BLK
|
+$24.2K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Solventum
SOLV
|
+$229K |
| 2 |
Waste Management
WM
|
+$203K |
| 3 |
SoFi Technologies
SOFI
|
+$176K |
| 4 |
UnitedHealth
UNH
|
+$73.5K |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$68.5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.82% |
| 2 | Industrials | 18.1% |
| 3 | Healthcare | 16.1% |
| 4 | Consumer Staples | 11.12% |
| 5 | Technology | 10.16% |
Similar funds
SW
USWG
SA
CWA
ACA
AIMU
PWA
ACMC
Creegan & Nassoura Financial Group's Q3 2024 Portfolio in Review
As of Q3 2024, Creegan & Nassoura Financial Group held 80 positions worth $159M, up 9% from $146M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Creegan & Nassoura Financial Group's Q3 2024 filing shows 2 new, 8 increased, 34 reduced and 3 closed positions. Its largest new stake was Eli Lilly: 232 shares worth $206K. The largest sale was Solventum, an estimated $229K.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Healthcare.
- Creegan & Nassoura Financial Group's largest Q3 2024 buy was Eli Lilly: 232 shares worth $206K.
- Creegan & Nassoura Financial Group added most to Chevron in Q3 2024, an estimated $1.27M increase.
- Creegan & Nassoura Financial Group's biggest Q3 2024 reduction was UnitedHealth, cutting an estimated $73.5K.
- Creegan & Nassoura Financial Group fully exited Solventum in Q3 2024, selling an estimated $229K.
- Creegan & Nassoura Financial Group's ten largest holdings make up 35% of its $159M portfolio in Q3 2024.
- Creegan & Nassoura Financial Group opened 2 new positions and closed 3 in Q3 2024.
- Creegan & Nassoura Financial Group's portfolio value rose 9% quarter-over-quarter to $159M.
Based on Creegan & Nassoura Financial Group's 13F filing for Q3 2024, filed 14 Nov 2024.